Inventor profile of:

Harald Duerr

City:

Starnberg

Country:

Germany

Published Applications:

24

Last publication date:

2025-11-27

Top Assignees for applications by Harald Duerr

The entities that hold a legal rights for patent applications filed by inventor Duerr Harald:

Recent patent applications by Duerr Harald

Harald Duerr from Starnberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27
US20250361279A1
Chemistry; metallurgy

New Interleukin-7 Immunoconjugates

#2 | 2025-10-16
US20250320305A1
Chemistry; metallurgy

BISPECIFIC ANTIGEN BINDING MOLECULES COMPRISING ANTI-FAP CLONE 212

#3 | 2025-09-25
US20250297025A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#4 | 2025-07-10
US20250223372A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#5 | 2025-06-05
US20250179205A1
Chemistry; metallurgy

NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP

#6 | 2025-01-30
US20250034269A1
Chemistry; metallurgy

AGONISTIC LTBR ANTIBODIES AND BISPECIFIC ANTIBODIES COMPRISING THEM

#7 | 2024-11-14
US20240376205A1
Chemistry; metallurgy

TARGETED INTERFERON ALPHA FUSION PROTEINS AND METHODS OF USE

#8 | 2024-09-26
US20240317879A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#9 | 2024-04-11
US20240117049A1
Chemistry; metallurgy

BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP

#10 | 2023-11-16
US20230365702A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#11 | 2023-07-06
US20230212277A1
Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES

#12 | 2022-09-29
US20220306761A1
Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#13 | 2022-07-21
US20220227878A1
Chemistry; metallurgy

Bispecific antigen binding molecules comprising anti-FAP clone 212

#14 | 2022-05-12
US20220144963A9
Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#15 | 2021-09-30
US20210301030A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#16 | 2021-04-01
US20210095013A1
Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES

#17 | 2020-07-09
US20200216554A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#18 | 2018-11-29
US20180340030A1
Chemistry; metallurgy

NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP

#19 | 2018-08-09
US20180222993A1
Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#20 | 2018-08-09
US20180222992A1
Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#21 | 2017-09-14
US20170260265A1
Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

#22 | 2016-12-29
US20160376304A1
Chemistry; metallurgy

Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography

#23 | 2014-01-16
US20140017244A1
Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

#24 | 2011-12-01
US20110293613A1
Chemistry; metallurgy

Bispecific antibodies

InventorID:

613652 ⎘